Fortis Healthcare Ltd has announced that its wholly owned subsidiary, International Hospital Ltd (IHL), has entered into a 15-year lease agreement with RR Lifesciences Ltd for a 200-bed operational multi-specialty hospital in Greater Noida. Previously managed by Fortis under an operations and management (O&M) arrangement since October 2022, the facility will now function as Fortis Hospital Greater Noida under the company’s direct operational and financial control.The hospital, located on a 1.35-acre UPSIDA-leased land parcel with a built-up area of 270,000 sq. ft., has scope for expanding bed capacity by an additional 50 beds, bringing its potential to approximately 250 beds. Strategically positioned, the hospital is connected via the Greater Noida Expressway, Metro (Aqua Line), Yamuna Expressway, and Eastern Peripheral Expressway, and lies about 34 km from the upcoming Jewar International Airport.This move enables Fortis to fully consolidate the hospital’s financials within its network and bolster its footprint in the rapidly urbanising NCR region. The Greater Noida area has witnessed sharp growth in population, residential development, and corporate presence in recent years, outpacing the existing healthcare infrastructure.Strategic Vision and CommentaryDr Ashutosh Raghuvanshi, MD & CEO of Fortis Healthcare Ltd, said:“The inclusion of Fortis Hospital Greater Noida underlines our commitment to enhancing healthcare accessibility across the NCR. With Greater Noida emerging as a vital urban and industrial hub, this expansion allows us to meet rising healthcare demand with patient-centric, high-quality tertiary care.”This development positions Fortis Healthcare to play a crucial role in meeting the region’s growing medical needs while contributing to Greater Noida’s emergence as a healthcare hub within Delhi-NCR. The move also aligns with Fortis’ broader strategy to expand its network, improve access, and deliver ethical, quality-driven healthcare services.